Cargando…
Influence of intravenous alteplase on endovascular treatment decision-making in acute ischemic stroke due to primary medium-vessel occlusion: a case-based survey study
BACKGROUND: Intravenous alteplase is currently the only evidence-based treatment for medium-vessel occlusion stroke (MeVO; M2/3, A2/3, and P2/3 vessel segment occlusions), but due to its limited efficacy, endovascular treatment (EVT) is increasingly performed in these patients. In this case-based su...
Autores principales: | Kappelhof, Manon, Ospel, Johanna, Kashani, Nima, Cimflova, Petra, Singh, Nishita, Almekhlafi, Mohammed A, Menon, Bijoy K, Fiehler, Jens, Chen, Michael, Sakai, Nobuyuki, Goyal, Mayank |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016248/ https://www.ncbi.nlm.nih.gov/pubmed/34035152 http://dx.doi.org/10.1136/neurintsurg-2021-017471 |
Ejemplares similares
-
Worldwide anaesthesia use during endovascular treatment for medium vessel occlusion stroke
por: Kappelhof, Manon, et al.
Publicado: (2021) -
Intracranial hemorrhage in large vessel occlusion patients receiving endovascular thrombectomy with or without intravenous alteplase: a secondary analysis of the DIRECT-MT trial
por: Hu, Xiaowei, et al.
Publicado: (2023) -
Endovascular Device Choice and Tools for Recanalization of Medium Vessel Occlusions: Insights From the MeVO FRONTIERS International Survey
por: Kashani, Nima, et al.
Publicado: (2021) -
Benefit and risk of intravenous alteplase in patients with acute large vessel occlusion stroke and low ASPECTS
por: Broocks, Gabriel, et al.
Publicado: (2023) -
Quantified health and cost effects of faster endovascular treatment for large vessel ischemic stroke patients in the Netherlands
por: van Voorst, Henk, et al.
Publicado: (2021)